Agree FG , the reason I have been in for so long is these guys have been doing proper work on proper products i am more concerned with recent moves towards “ early entry to unregulated markets” putting a product on the market on Amazon with no evidence in a very competitive foreign market etc Products with evidence in regulated markets was what we were about and that was why they have been so good with managing the funds and getting real work done on CPat 1 and DermaCann . Quick revenue and no substance has most cannabis stocks dying in the ditch !!! I hope these guys haven’t lost there nerve and following the pump and dumpers
CP1 Price at posting:
12.0¢ Sentiment: Buy Disclosure: Held
